- Home
- ACON vs CNSP Comparison
ACON vs CNSP Comparison
Compare ACON & CNSP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ACON
- CNSP
- Stock Information
- Founded
- ACON 2008
- CNSP 2017
- Country
- ACON United States
- CNSP United States
- Employees
- ACON N/A
- CNSP N/A
- Industry
- ACON Retail: Computer Software & Peripheral Equipment
- CNSP Biotechnology: Pharmaceutical Preparations
- Sector
- ACON Technology
- CNSP Health Care
- Exchange
- ACON Nasdaq
- CNSP Nasdaq
- Market Cap
- ACON 4.3M
- CNSP 4.0M
- IPO Year
- ACON 2022
- CNSP 2019
- Fundamental
- Price
- ACON $7.15
- CNSP $6.19
- Analyst Decision
- ACON Buy
- CNSP Hold
- Analyst Count
- ACON 2
- CNSP 1
- Target Price
- ACON $481.00
- CNSP N/A
- AVG Volume (30 Days)
- ACON 9.0K
- CNSP 79.4K
- Earning Date
- ACON 08-14-2025
- CNSP 08-14-2025
- Dividend Yield
- ACON N/A
- CNSP N/A
- EPS Growth
- ACON N/A
- CNSP N/A
- EPS
- ACON N/A
- CNSP N/A
- Revenue
- ACON $62,948.00
- CNSP N/A
- Revenue This Year
- ACON $145.39
- CNSP N/A
- Revenue Next Year
- ACON $145.45
- CNSP N/A
- P/E Ratio
- ACON N/A
- CNSP N/A
- Revenue Growth
- ACON 16.68
- CNSP N/A
- 52 Week Low
- ACON $6.20
- CNSP $4.93
- 52 Week High
- ACON $3,499.51
- CNSP $221.94
- Technical
- Relative Strength Index (RSI)
- ACON 46.50
- CNSP 42.48
- Support Level
- ACON $6.82
- CNSP $5.85
- Resistance Level
- ACON $7.36
- CNSP $6.37
- Average True Range (ATR)
- ACON 0.35
- CNSP 0.68
- MACD
- ACON 0.01
- CNSP 0.13
- Stochastic Oscillator
- ACON 35.29
- CNSP 48.87
About ACON Aclarion Inc.
Aclarion Inc is a healthcare technology company that leverages Magnetic Resonance Spectroscopy (MRS), and a proprietary biomarker to optimize clinical treatments. Its product Nociscan is a SaaS platform that leverages MR Spectroscopy to noninvasively help physicians distinguish between painful and nonpainful discs in the spine. The company derives its revenues from one source, the delivery of Nociscan reports to medical professionals. Substantially all revenues are generated from contracts with customers in the United States.
About CNSP CNS Pharmaceuticals Inc.
CNS Pharmaceuticals Inc is a clinical-stage pharmaceutical company focused on the development of anticancer drug candidates for the treatment of primary and metastatic brain and central nervous system tumors. It is involved in the development of Berubicin, which is a therapy for the treatment of glioblastoma. Glioblastomas are tumors that arise from astrocytes, which are star-shaped cells that make up the supportive tissue of the brain.